Associate Clinical Professor of Surgery, Beth Israel Deaconess Medical Center
Urology
Dr. Abraham Morgentaler, MD
Doctor Abraham Morgentaler, MD is an expert in the field of Urology. He went to medical school at Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received 5 awards: "Boston Magazine", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACS)", "Super Doctor" and "Top MD". Abraham Morgentaler is also a published doctor. He has 31 publication published. The most recent publication is: International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic. He is registered with Medicare.
Publications
- International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic.
- Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.
- The practical management of testosterone deficiency in men.
- Testosterone and cardiovascular Disease - the controversy and the facts.
- RE: Testosterone Treatment Is a Potent Tumor Promoter for the Rat Prostate.
- Factors Influencing Prostate-Specific Antigen Response among Men Treated with Testosterone Therapy for 6 Months.
- Will I have a heart attack or stroke if I take testosterone therapy?
- Testosterone, Cardiovascular Risk, and Hormonophobia.
- Commentary: Who Is a Candidate for Testosterone Therapy? A Synthesis of International Expert Opinions.
- Testosterone and cardiovascular risk: world's experts take unprecedented action to correct misinformation.
- Reply to Julia Klap and Kevin R. Loughlin's Letter to the Editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A New Era of Tes...
- Medical Hypothesis: Loss of the Endocrine Function of the Prostate Is Important to the Pathophysiology of PostProstatectomy Erectile Dysfunction.
- Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual Dysfunction or infertility.
- Does Testosterone Increase the Risk of a Cardiovascular Event?
- Deaths and cardiovascular events in men receiving testosterone.
- Death by testosterone? We think not!
- Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
- Andrology: Testosterone and cardiovascular risk-deciphering the statistics.
- Free testosterone by direct and calculated measurement versus equilibrium dialysis in a clinical population.
- The Evaluation and Management of Testosterone Deficiency: the New Frontier in Urology and Men's Health.
- A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications.
- RE: Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate Cancer.
- Testosterone therapy in men with prostate Cancer: scientific and ethical considerations.
- Estrogens in men: clinical implications for Sexual function and the treatment of testosterone deficiency.
- A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion.
- Influence of baseline serum testosterone on changes in body composition in response to testosterone therapy.
- Testosterone deficiency and Peyronie's Disease: pilot data suggesting a significant relationship.
- Two years of testosterone therapy associated with decline in prostate-specific antigen in a man with untreated prostate Cancer.
- Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.
- Testosterone therapy in men with prostate Cancer: literature review, clinical experience, and recommendations.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Deaconess Hospital
Harvard University
Procedures Preformed
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Lithotripsy
- Penile Implants
- TURP (Transurethral Resection of Prostate) or Laser Destruction of Prostate
- View All
Conditions Treated
- Bladder Cancer
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- Elevated PSA (Prostate Specific Antigen)
- View All
Doctors Specialties
Accepted Insurances
Awards
- Boston Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Super Doctor
- Top MD
Education
-
Brigham and Women's Hospital
-
Beth Israel Deaconess Medical Center
-
Harvard Medical School
Hospital
-
Beth Israel Deaconess Medical Center
-
Brigham and Women's Faulkner Hospital
Drug Facts
| NPI NUMBER |
|
1679505101 |
| NPPES Provider LastName |
|
MORGENTALER |
| NPPES Provider FirstName |
|
ABRAHAM |
| NPPES Provider ZIPCode |
|
022153401 |
| NPPES Provider State |
|
MA |
| Specialty Description |
|
Urology |
| Total Claim Count |
|
483.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1679505101 |
| Last Name Of The Provider |
MORGENTALER |
| First Name Of The Provider |
ABRAHAM |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.